About Paragonix Technologies
Paragonix Technologies is a company based in Boston (United States) founded in 2010 was acquired by Getinge in August 2024. Paragonix Technologies has raised $25.1 million across 4 funding rounds from investors including Getinge, HHS and Signet Healthcare Partners. Paragonix Technologies offers products and services including SherpaPak Cardiac Preservation, LUNGguard Organ Preservation, BAROguard Lung Preservation, KidneyVault Renal Perfusion, and Paragonix App. Paragonix Technologies operates in a competitive market with competitors including TransMedics, OrganOx, Bridge to Life, Vascular Perfusion and ADVITOS, among others.
- Headquarter Boston, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Paragonix Technologies, Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Paragonix Technologies
Paragonix Technologies offers a comprehensive portfolio of products and services, including SherpaPak Cardiac Preservation, LUNGguard Organ Preservation, BAROguard Lung Preservation, KidneyVault Renal Perfusion, and Paragonix App.
Preserves hearts during transport with controlled temperatures
Maintains optimal conditions for lungs in transit
Ensures lung preservation through temperature monitoring
Provides perfusion for kidneys during transportation
Offers real-time tracking and monitoring for organ logistics
People of Paragonix Technologies
Unlock access to complete
Unlock access to complete
Funding Insights of Paragonix Technologies
Paragonix Technologies has successfully raised a total of $25.1M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $24 million completed in March 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Paragonix Technologies
Paragonix Technologies has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Getinge, HHS and Signet Healthcare Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
PE firm investing in North America and Europe
|
Locked | Locked | Locked | |
|
Life sciences innovation is supported through funding and programs.
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Paragonix Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Paragonix Technologies
Investment portfolio details for Paragonix Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Paragonix Technologies
Detailed financials for Paragonix Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Paragonix Technologies Comparisons
Peer comparison for Paragonix Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Paragonix Technologies
Paragonix Technologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TransMedics, OrganOx, Bridge to Life, Vascular Perfusion and ADVITOS, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of organ transplantation technology
|
|
| Locked | Locked | Locked |
Warm storage and transport systems for harvested organs are provided.
|
|
| Locked | Locked | Locked |
Cold storage solutions for organ transplant preservation are provided.
|
|
| Locked | Locked | Locked |
Developer of a device for organ preservation
|
|
| Locked | Locked | Locked |
Multi-organ support systems for liver, lung, and kidney are provided.
|
Detailed competitors of Paragonix Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Paragonix Technologies
Complete news archive for Paragonix Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Paragonix Technologies
Paragonix Technologies was founded in 2010 and raised its 1st funding round 1 year after it was founded.
Paragonix Technologies is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Paragonix Technologies is a funded company, having raised a total of $25.1M across 4 funding rounds to date.
Paragonix Technologies was founded in 2010 and is headquartered in Boston, United States. Operations center on the medical device sector, with development of systems for organ preservation and transport in transplantation. Intellectual property has been exclusively licensed from the Board of Regents of The University of Texas. Products include SherpaPak for hypothermic storage, SherpaKit integrating transport with preservation solutions, SherpaPerfusion for oxygenated perfusion, and SherpaTrak for organ tracking.
Paragonix Technologies's top competitors include TransMedics, OrganOx and ADVITOS.
Paragonix Technologies offers SherpaPak Cardiac Preservation, LUNGguard Organ Preservation, BAROguard Lung Preservation, KidneyVault Renal Perfusion, and Paragonix App.
Paragonix Technologies has 4 investors. Key investors include Getinge, HHS, Signet Healthcare Partners, and Massachusetts Life Sciences Center.